Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study
Articolo
Data di Pubblicazione:
2010
Citazione:
Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study / M.R. Cesarone, G. Belcaro, E. Ippolito, L. Pellegrini, A. Ledda, R. Luzzi, A. Ricci, M. Dugall, P. Bavera, M. Hosoi, S. Stuard, M. Corsi. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - 52:2 Suppl 1(2010 Jun), pp. 43-48.
Abstract:
This study evaluated the clinical efficacy of Venoruton (O-(beta-hydroxyethyl)-rutosides) (HR) (Novartis Consumer Healthcare) in subjects with severe chronic venous insufficiency (CVI).
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Hydroxyethylrutoside; Stockings, Compression; Humans; Aged; Laser-Doppler Flowmetry; Registries; Blood Pressure Monitoring, Ambulatory; Cost-Benefit Analysis; Venous Insufficiency; Adult; Chronic Disease; Middle Aged; Microcirculation; Female; Male
Elenco autori:
M.R. Cesarone, G. Belcaro, E. Ippolito, L. Pellegrini, A. Ledda, R. Luzzi, A. Ricci, M. Dugall, P. Bavera, M. Hosoi, S. Stuard, M. Corsi
Link alla scheda completa: